Clinic
1405 NW 167th Street
Miami Gardens, FL 33169
Ph: 305.624.9191
Fax: 305.623.7772
Central Lab
1525 NW 167th Street, Suite 140
Miami Gardens, FL 33169
Ph: 305.625.2183 |
Cetero’s Miami facility incorporates a team with extensive clinical and central lab services into one location.
Designed to run clinical pharmacology studies in normal healthy and special populations, Miami has conducted more than 200 studies since May 2006. This facility has an astounding enrollment panel fill rate of 98 percent and exhibits more than 95 percent compliance and study completion.
Built to allow for maximum flexibility and safety, Miami has 137-beds, including a 17-bed intensive observation unit.
We can provide telemetry monitoring for more than 32 subjects at a time, with a board-certified cardiologist acting as a real-time/live cardiac safety monitor. Even the most complex studies to be completed with subject safety in mind. In addition, we have the ability to conduct imaging studies utilizing MRI, CT scan and ultrasound technologies.
Located next to the clinical facility, our full-service central lab offers more than 25 years of experience working with custom-designed profiles, packaging and logistics for all phases of clinical trials.
Contact us today to discuss your next project at 877.7CETERO, or miami@cetero.com.
|
Miami Facility
| • |
25,000 sq. ft. clinic |
| • |
137 beds |
| • |
17 ICU beds |
| • |
In-house central laboratory
| • |
CLIA, COLA and CAP certification |
| • |
AHCA accreditation |
| • |
Proficiency testing through AAB and CAP |
|
| • |
Direct access to Cetero’s bioanalytical expertise |
| • |
Ability to identify, enroll and randomize special populations including: |
| |
| • |
Actinic keratosis |
| • |
Children |
| • |
Diabetes (Type 1 and Type 2) |
| • |
Elderly |
| • |
Hepatic-impaired |
| • |
Renal-impaired (mild, moderate, severe and ESRD) |
| • |
Postmenopausal Women |
|
|
